loading
前日終値:
$123.02
開ける:
$131.54
24時間の取引高:
69,347
Relative Volume:
0.15
時価総額:
$70.38M
収益:
$7.10M
当期純損益:
$-39.43M
株価収益率:
-132.87
EPS:
-0.94
ネットキャッシュフロー:
$-46.50M
1週間 パフォーマンス:
-3.50%
1か月 パフォーマンス:
+1,513%
6か月 パフォーマンス:
-86.69%
1年 パフォーマンス:
-90.34%
1日の値動き範囲:
Value
$118.10
$131.54
1週間の範囲:
Value
$112.95
$144.00
52週間の値動き範囲:
Value
$7.26
$543.38

Spruce Biosciences Inc Stock (SPRB) Company Profile

Name
名前
Spruce Biosciences Inc
Name
セクター
Healthcare (1145)
Name
電話
(415) 655-4168
Name
住所
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Name
職員
20
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
SPRB's Discussions on Twitter

SPRB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SPRB
Spruce Biosciences Inc
125.00 69.32M 7.10M -39.43M -46.50M -0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
419.33 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.89 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.23 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
828.95 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
166.45 34.67B 398.11M -1.03B -868.57M -5.7032

Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-11 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-12-11 ダウングレード Oppenheimer Outperform → Perform
2024-03-14 ダウングレード Guggenheim Buy → Neutral
2024-03-14 ダウングレード H.C. Wainwright Buy → Neutral
2024-03-14 ダウングレード Ladenburg Thalmann Buy → Neutral
2024-03-14 ダウングレード Leerink Partners Outperform → Market Perform
2024-03-14 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-02-21 開始されました Guggenheim Buy
2021-12-17 開始されました Oppenheimer Outperform
2021-12-10 開始されました The Benchmark Company Speculative Buy
2021-11-16 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-07-19 開始されました H.C. Wainwright Buy
2021-04-26 再開されました Credit Suisse Outperform
2020-11-03 開始されました Cowen Outperform
2020-11-03 開始されました Credit Suisse Outperform
2020-11-03 開始されました RBC Capital Mkts Outperform
2020-11-03 開始されました SVB Leerink Outperform
すべてを表示

Spruce Biosciences Inc (SPRB) 最新ニュース

pulisher
10:25 AM

SPRB: JMP Securities Upgrades Spruce Biosciences to Market Outpe - GuruFocus

10:25 AM
pulisher
05:01 AM

Spruce Biosciences stock upgraded by Citizens on promising MPS IIIB therapy - Investing.com Nigeria

05:01 AM
pulisher
Oct 24, 2025

Levi & Korsinsky Reminds Spruce Biosciences Investors of the Ongoing Investigation into Potential Violations of Securities LawsSPRB - ACCESS Newswire

Oct 24, 2025
pulisher
Oct 22, 2025

Spruce Biosciences CFO vests 2,053 RSUs; owns 6,066 shares - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

SPRB insider filing: CEO nets 3,245 shares after RSU vest - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

The science behind the therapy that catapulted a biopharma’s stock 1,400% and counting - healthcare-brew.com

Oct 22, 2025
pulisher
Oct 22, 2025

Leerink Partners Maintains Spruce Biosciences (SPRB) Market Perform Recommendation - Nasdaq

Oct 22, 2025
pulisher
Oct 21, 2025

Spruce Biosciences (SPRB): Analyst Raises Price Target Significa - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Spruce Biosciences stock price target raised to $160 from $10 at Leerink - Investing.com Philippines

Oct 21, 2025
pulisher
Oct 20, 2025

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025) - ts2.tech

Oct 20, 2025
pulisher
Oct 20, 2025

Mintz Advises the Placement Agents in Spruce Biosciences, Inc.’s $50 Million Private Placement - Mintz

Oct 20, 2025
pulisher
Oct 19, 2025

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough News – Experts Weigh In - ts2.tech

Oct 19, 2025
pulisher
Oct 19, 2025

Spruce Biosciences (NASDAQ:SPRB) Upgraded at Zacks Research - Defense World

Oct 19, 2025
pulisher
Oct 18, 2025

SPRUCE BIOSCIENCES, INC. trading resumes - MSN

Oct 18, 2025
pulisher
Oct 17, 2025

SPRB director steps down; company notes no disagreement - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

Spruce Biosciences, Inc. Announces Resignation of Bali Muralidhar as Member of Board of Directors and as Member of the Compensation Committee of the Board, Effective October 15, 2025 - MarketScreener

Oct 17, 2025
pulisher
Oct 16, 2025

Spruce Biosciences Stock More Than Quadruples After Breakthrough Therapy Designation To Therapy For Rare And Fatal Genetic Disease - MSN

Oct 16, 2025
pulisher
Oct 16, 2025

Head to Head Contrast: PyroGenesis Canada (NASDAQ:PYRGF) vs. Spruce Biosciences (NASDAQ:SPRB) - Defense World

Oct 16, 2025
pulisher
Oct 15, 2025

What Makes Spruce Biosciences, Inc. (SPRB) a Strong Momentum Stock: Buy Now? - sharewise.com

Oct 15, 2025
pulisher
Oct 15, 2025

Spruce Biosciences’ (SPRB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Spruce Biosciences insider filing shows 256-share buy, 1,050 held - Stock Titan

Oct 15, 2025
pulisher
Oct 14, 2025

Spruce Biosciences to sell 502,181 shares at $68.00 in private placement - MSN

Oct 14, 2025
pulisher
Oct 11, 2025

Spruce Biosciences (NASDAQ:SPRB) Shares Down 1% – What’s Next? - Defense World

Oct 11, 2025
pulisher
Oct 11, 2025

Spruce Biosciences (NASDAQ:SPRB) Shares Down 1%What's Next? - MarketBeat

Oct 11, 2025
pulisher
Oct 09, 2025

Medical Stocks To ConsiderOctober 6th - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Promising Pharmaceutical Stocks Worth WatchingOctober 6th - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 By Investing.com - Investing.com UK

Oct 09, 2025
pulisher
Oct 08, 2025

Spruce Biosciences, Inc. announced that it has received $49.999769 million in funding - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 - Investing.com India

Oct 08, 2025
pulisher
Oct 08, 2025

SPRUCE BIOSCIENCES, INC. trading halted, volatility trading pause - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences announces $50M private placement financing - TipRanks

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50M for Therapy Advancements - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Three Biotech Stocks Jump After Big Regulatory Wins - Finimize

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50M for Enzyme Replacement Th - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences to Raise $50 Million Through Private Placement; Shares Down Pre-Bell - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50 Million for Enzyme Therapy Development - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences secures $50 million in private placement By Investing.com - Investing.com Canada

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences secures $50 million in private placement - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50M in Private Placement for Therapy Advancement - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Bio jumps after breakthrough therapy status for enzyme replacement therapy - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences announces $50.0 million private placement financing - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent

Oct 08, 2025
pulisher
Oct 08, 2025

Small Cap Stocks To Follow Today – October 6th - Defense World

Oct 08, 2025
pulisher
Oct 08, 2025

Understanding the Current Trends in SPRB Stock - Info Petite Nation

Oct 08, 2025
pulisher
Oct 08, 2025

Medical Stocks To Consider – October 6th - Defense World

Oct 08, 2025
pulisher
Oct 07, 2025

Biotech And Tech Stocks Rally On Breakthrough News And Partnerships - Finimize

Oct 07, 2025
pulisher
Oct 07, 2025

Spruce Biosciences Stock: Emergent Surges and Market Implications - timothysykes.com

Oct 07, 2025
pulisher
Oct 07, 2025

SPRB Stock Hits 19-Month High Amid Trading Halts - NewsBreak: Local News & Alerts

Oct 07, 2025
pulisher
Oct 07, 2025

Spruce Biosciences’ Breakthrough: Stock Skyrockets - StocksToTrade

Oct 07, 2025
pulisher
Oct 07, 2025

Spruce Biosciences Soars: What’s Driving the Surge? - timothysykes.com

Oct 07, 2025

Spruce Biosciences Inc (SPRB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Spruce Biosciences Inc (SPRB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Szwarcberg Javier B.
CHIEF EXECUTIVE OFFICER
Oct 20 '25
Option Exercise
0.00
4,784
0
11,013
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Buy
17.91
256
4,585
1,307
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Sale
19.14
257
4,920
1,050
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Buy
17.91
256
4,585
1,307
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Sale
19.14
257
4,920
1,050
$36.43
price down icon 2.04%
$88.90
price down icon 4.38%
$29.09
price up icon 0.10%
$106.17
price up icon 0.13%
biotechnology ONC
$316.35
price up icon 0.32%
$166.45
price up icon 1.48%
大文字化:     |  ボリューム (24 時間):